Telegram RegisterThe public register of Telegram
Telegram profile photo for 에이프릴바이오 공식IR채널: 리레이팅 2026

Channel

에이프릴바이오 공식IR채널: 리레이팅 2026

@aprilbioipr

On this record: Topic · Growth · Engagement · Reactions · Posts · Citations · Cite this entry

4,498subscribers

+78 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 3,162–10,000.

Register entry

Telegram ID-1002105596818
TypeChannel
Username@aprilbioipr
CreatedBetween 1 November 2023 and 31 May 2024 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded6 August 2026
Last confirmed live16 September 2026
Measurements held15
Confirmed unchanged1 time, most recently 16 September 2026
On Telegramt.me/aprilbioipr

Topic

Other / unclassifiable — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 13 September 2026 and assigned it the closest of 31 fixed categories, at 94% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Growth

4,3984,5454,471.56 August 2026 — 4,420 subscribers6 August 2026 — 4,420 subscribers6 August 2026 — 4,419 subscribers9 August 2026 — 4,417 subscribers12 August 2026 — 4,408 subscribers15 August 2026 — 4,402 subscribers18 August 2026 — 4,398 subscribers22 August 2026 — 4,545 subscribers25 August 2026 — 4,540 subscribers28 August 2026 — 4,534 subscribers31 August 2026 — 4,542 subscribers4 September 2026 — 4,534 subscribers9 September 2026 — 4,532 subscribers13 September 2026 — 4,509 subscribers16 September 2026 — 4,498 subscribers4,4986 August 202616 September 2026
15 measurements spanning 42 days, net +78. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 4,376–4,567 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
16 Sept 2026, 18:374,498-11
13 Sept 2026, 02:364,509-23
9 Sept 2026, 00:364,532-2
4 Sept 2026, 00:564,534-8
31 Aug 2026, 09:544,542+8
28 Aug 2026, 08:074,534-6
25 Aug 2026, 05:124,540-5
22 Aug 2026, 04:364,545+147
18 Aug 2026, 10:034,398-4
15 Aug 2026, 17:534,402-6
12 Aug 2026, 02:434,408-9
9 Aug 2026, 10:314,417-2
6 Aug 2026, 10:204,419-1
6 Aug 2026, 04:044,420no change
6 Aug 2026, 03:374,420first reading

Engagement

20 posts held, back to 25 June 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 6 pages of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 5 August 2026. An engagement rate over an empty window would be a number about nothing.

Reaction mix

888 reactions across 20 posts, in 11 distinct kinds. The most used accounts for 28.8% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👍25628.8%
25428.6%
💩24227.3%
🔥444.95%
🤬364.05%
👎212.36%
👌161.80%
😱91.01%
🤔50.563%
💯30.338%
🙏20.225%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 20 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 888 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 25 June 2026 to 5 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

5 Aug 2026, 13:56 UTC≈16,500 views48 reactionsread 8 August 2026
Photo

오는 9월 30일 EADV학회에서 APB-R3 2a상 탑라인 결과발표가 예정되어있습니다. 제목이 ‘positive’ data발표라는 점이 눈에 띕니다.

32👍10💩5🤬1

24 Jul 2026, 14:01 UTC≈2,710 views37 reactionsread 8 August 2026
Forwarded from @allbioboss

https://www.hkn24.com/news/articleView.html?idxno=350486&utm_source=chatgpt.com

🔥16💩96👍6

23 Jul 2026, 22:46 UTC≈1,840 views26 reactionsread 8 August 2026
Forwarded from @darthacking

2026.07.24 07:45:28 기업명: 에이프릴바이오(시가총액: 6,216억) A397030 보고서명: 최대주주변경 * 변경전 최대주주 주주명 : 차상훈 외 2인 지분율 : 19.39% * 변경후 최대주주 주주명 : 아이엠엠헬스케어 제8호 유한회사 외 2인 지분율 : 19.22% 변경사유 : 최대주주 지분 취득 및 제3자배정 유상증자 납입을 통한 최대주주 변경 인수목적 : 단순투자 변경일자 : 2026-07-23 의무보유 : 예 * 기타 참고사항 차입기간 공시링크: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260724900005 회사정보: https://finance.naver.com/item/main.nhn?code=397030

👍16💩64

23 Jul 2026, 09:05 UTC≈2,850 views20 reactionsread 8 August 2026

https://m.etoday.co.kr/news/view/2606815

9👍6💩5

23 Jul 2026, 07:56 UTC≈6,780 views28 reactionsread 8 August 2026
Photo

Photo, posted without a caption

21💩5👍2

23 Jul 2026, 05:38 UTC≈4,510 views55 reactionsread 8 August 2026

납입완료되었습니다

32👍14💩7🙏2

23 Jul 2026, 05:38 UTC≈1,490 views44 reactionsread 8 August 2026

📌 [주요] 💰 [에이프릴바이오] 25,250원 (🔺3.06%) | 시총 5,912억 증권발행결과(자율공시) (제3자배정 유상증자-의결권부전환우선주) 1. 증권의 종류: 기명식 의결권 전환우선주식 2. 발행방법: 제3자배정 유상증자 발행예정주식수(주): 3,608,595 발행예정금액(원): 154,999,981,035 발행결정 최초 이사회결의일: 2026-06-24 실제발행금액(원): 154,999,981,035 납입일: 2026-07-23 4. 상장예정 여부: 아니오 5. 기타 투자판단에 참고할 사항: - 본 유상증자에 의하여 발행되는 신주는 그 유통일(전자등록일)로부터 1년간 한국예탁결제원에 보호예수됩니다. ※관련공시: 2026-06-25 유상증자결정(제3자배정-의결권부전환우선주) 2026-07-23 경영권 변경 등에 관한 계약 체결 🔗

24👍10💩9💯1

22 Jul 2026, 01:09 UTC≈8,190 views19 reactionsread 8 August 2026

https://n.news.naver.com/article/008/0005389089?sid=101

💩12🔥5💯2

21 Jul 2026, 09:31 UTC≈1,160 views26 reactionsread 8 August 2026

📌 에이프릴바이오(시가총액: 5,502억) #A397030 📁 투자판단관련주요경영사항 (기술도입 계약 체결) 2026.07.21 18:28:58 (현재가 : 23,500원, -2.08%) 제목 : 기술도입 계약 체결 * 주요내용 ※ 투자유의사항 동 계약은 조건부 계약으로서, 본 계약을 통한 비용 인식은 임상시험과 품목허가 등의 성공 여부에 따라 달라질 수 있습니다. 계약 조건에 따라, 규제기관에 의한 연구ㆍ개발의 중단, 품목허가 실패 등 발생 시 계약이 해지될 수 있습니다. 1) 계약상대방: 큐리진 2) 계약의 내용: 큐리진社가 보유한 이중타겟 siRNA 플랫 폼 기반 대사질환 치료제 신약 후보 물질의 기술도입 3) 계약체결일: 2026.7.21 4) 계약 기간: 아래 기간 중 가장 늦은날 가. 해당

18💩6👍1🤬1

20 Jul 2026, 01:39 UTC≈8,020 views30 reactionsread 8 August 2026

https://www.mt.co.kr/thebio/2026/07/20/2026072010222491569

👍16💩14

12 Jul 2026, 09:32 UTC≈8,140 views70 reactionsread 8 August 2026

"4000억 R&D 투자…내년 복수 기술이전 목표" https://www.hankyung.com/article/2026071201431 차상훈 에이프릴바이오 대표 TKG그룹 피인수 후 첫 인터뷰 “신규 플랫폼 기술 리맵(REMAP)으로 내년 중 두 건의 기술이전을 달성하는 게 목표입니다.” 차세대 성장동력은 항체올리고펩타이드접합체(AOC)다. “이르면 하반기 siRNA를 이용한 항암제 후보물질의 공동 개발을 시작할 수 있을 것으로 기대한다”

35💩23👍7👎5

8 Jul 2026, 04:50 UTC≈7,450 views56 reactionsread 8 August 2026

https://www.hankyung.com/article/202607082761i TKG그룹 “에이프릴바이오 투자, 공시 조건대로 이행”

👍25💩20🤬8👎3

Showing the 12 most recent of 20 posts we hold for @aprilbioipr. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 16 September 2026 — this entry's latest reading, not the date you are reading this.

“에이프릴바이오 공식IR채널: 리레이팅 2026” (@aprilbioipr), 4,498 subscribers as measured 16 September 2026. Telegram Register, tgregister.com/channel/aprilbioipr.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.